Combination of rapamycin and trametinib extends mouse lifespan by about 30%, study finds

Researchers at the Max Planck Institute for Biology of Aging have discovered that the combination of the two cancer drugs, rapamycin and trametinib, significantly extends the lifespan of mice. The work has been published in Nature Aging.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup